Breast Cancer Information - December 3, 2008

Gene Pattern May Indicate Spread of Breast Cancer

July 28, 2005 - Topics breast cancer, cancer, disease, study and research
Scientists may have pinpointed a telltale set of genes which appear to predict if breast cancer will spread to the lungs.

A team from the Memorial Sloan-Kettering Cancer Center says the genetic "signature" may help predict how serious the disease may be

read more >>

Green Tea Most Likely Not A Cancer Elixir

June 30, 2005 - Topics cancer, breast cancer, food, studies and fda
Green tea probably does not help prevent breast, prostate or any other type of cancer, the U.S. Food and Drug Administration said on Thursday.

THE F.D.A. went on to say that studies supporting the assertions about the medical power of green tea are weak

read more >>

Experimental Drug Combination Lethal for Breast Cancer Subjects

May 18, 2005 - Topics breast cancer, cancer, disease, blood and infection

Christina Ficara - All Headline News Staff Reporter

The problems developed in women given the standard intravenous drug doxorubicin along with a newer drug called docetaxel. The two drugs are frequently used alone to treat breast cancer. Scientists have been exploring the effects of combining them, with mixed results

read more >>

Glaxo's Experimental Cancer Pill Will Not Seek Review Until Late 2006

May 15, 2005 - Topics cancer, women and breast cancer
GlaxoSmithKline Plc's experimental cancer pill, Lapatinib, is effective as a first-line breast cancer treatment, but regulatory approval will not be sought before late 2006 or early 2007 after more data is collected.

London-based Glaxo said interim results from a mid-stage trial of the drug in 40 women with advanced breast cancer showed that 35 percent had their tumors shrink by at least 30 percent

read more >>

Drug and Chemo Therapy Aides Patients With Advanced Lung, Breast Cancer

May 14, 2005 - Topics breast cancer, cancer, disease, blood and research
Researchers discovered that patients with advanced lung cancer or advanced breast cancer who took Genentech Inc.'s cancer drug Avastin in combination with chemotherapy took longer to relapse than patients who took chemotherapy alone.

The data from two late-stage trials was released at the annual meeting of the American Society of Clinical Oncology in Orlando, Florida

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use